SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-16-075892
Filing Date
2016-08-11
Accepted
2016-08-11 16:11:23
Documents
41
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 ONCOCYTE CORPORATION 10-Q 6-30-2016 form10q.htm 10-Q 362141
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 28501
3 EXHIBIT 31 ex31.htm EX-31 12855
4 EXHIBIT 32 ex32.htm EX-32 4479
  Complete submission text file 0001140361-16-075892.txt   2235678

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ocx-20160630.xml EX-101.INS 290845
6 XBRL TAXONOMY EXTENSION SCHEMA ocx-20160630.xsd EX-101.SCH 22908
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocx-20160630_cal.xml EX-101.CAL 35909
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocx-20160630_def.xml EX-101.DEF 84865
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocx-20160630_lab.xml EX-101.LAB 336315
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocx-20160630_pre.xml EX-101.PRE 188426
Mailing Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502 510-521-3390
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 161824683
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences